SAN ANTONIO, Texas--( BUSINESS WIRE )--NucleoBio, Corp., a leading biotechnology innovator in precision oncology diagnostics, and PreCheck Health Services, a high-complexity CLIA-certified and CAP-accredited clinical laboratory, today announced a strategic collaboration to support clinical development and processing of the proprietary Prostac™ assay. This partnership aims to enable future application of the test across a broader clinical setting, supporting ongoing research a

We’re losing too many Black men to prostate cancer First Published in Rollout Magazine 1/12/2024 By Mr. Digital Fingers Jan 12, 2024 10:32 am Prostate health stands as a cornerstone of overall well-being, with particular importance for Black men who can significantly benefit from understanding their father’s health history. This article delves into the pivotal role that familial medical backgrounds play in shaping a proactive approach to individual health, specifically focus

Prostate cancer is one of the most common cancers among men, with early detection being crucial for successful treatment. NucleoBio, a cutting-edge biotech company, has developed a revolutionary blood-based test that aims to change the landscape of prostate cancer diagnosis. This groundbreaking test offers precision diagnosis, empowering physicians to tailor personalized interventions for their patients. Traditionally, prostate cancer diagnosis involved invasive procedures th

Prostate cancer is the second most common cancer among men worldwide, making it a significant health concern that should not be overlooked. While many may feel uncomfortable discussing or undergoing screenings for prostate cancer, early detection can be a lifesaver. This is where educational videos come into play, to shed light on the importance of annual prostate tests and encourage men to prioritize their health. NucleoBio, a leading biotech company, has taken a groundbreak

Prostate cancer is one of the most common forms of cancer that affect men globally. It is crucial to detect this cancer early to allow...